AR010041A1 - Agonistas multifuncionales quimericos de receptores de hematopoyetina - Google Patents
Agonistas multifuncionales quimericos de receptores de hematopoyetinaInfo
- Publication number
- AR010041A1 AR010041A1 ARP970104979A ARP970104979A AR010041A1 AR 010041 A1 AR010041 A1 AR 010041A1 AR P970104979 A ARP970104979 A AR P970104979A AR P970104979 A ARP970104979 A AR P970104979A AR 010041 A1 AR010041 A1 AR 010041A1
- Authority
- AR
- Argentina
- Prior art keywords
- agonists
- multifunctional
- hematopoyetin
- receptors
- hematopoietin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se revelan nuevas proteínas con agonista multifuncional quimérico de receptor de hematopoyetina, los ADNs que codifican las proteínas con agonistasmultifuncionales quiméricos de receptores de hematopoyetina, método para hacer proteína con agonistas multifuncinales quiméricos de receptor de hematopoyetinay método para utilizar proteína con agonistas multifuncinales quimérico de receptor de hematopoyetina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2962996P | 1996-10-25 | 1996-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010041A1 true AR010041A1 (es) | 2000-05-17 |
Family
ID=21850035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970104979A AR010041A1 (es) | 1996-10-25 | 1997-10-28 | Agonistas multifuncionales quimericos de receptores de hematopoyetina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0935663A2 (es) |
JP (1) | JP2001504689A (es) |
KR (1) | KR100497423B1 (es) |
AR (1) | AR010041A1 (es) |
AU (1) | AU725547B2 (es) |
BR (1) | BR9713668A (es) |
CA (1) | CA2268742A1 (es) |
CZ (1) | CZ295843B6 (es) |
IL (1) | IL129565A0 (es) |
NO (1) | NO991948L (es) |
NZ (1) | NZ335382A (es) |
PL (1) | PL333023A1 (es) |
RO (1) | RO120919B1 (es) |
RU (2) | RU2245887C2 (es) |
TW (2) | TW591035B (es) |
WO (1) | WO1998017810A2 (es) |
ZA (1) | ZA979607B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO1998046750A1 (en) * | 1997-04-11 | 1998-10-22 | G.D. Searle & Co. | flt3 LIGAND CHIMERIC PROTEINS |
BR9905867A (pt) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula |
WO2002101047A1 (en) * | 2001-06-12 | 2002-12-19 | Smithkline Beecham Corporation | Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities |
AU2002325819B2 (en) | 2001-07-11 | 2008-06-19 | Maxygen, Inc. | G-CSF Conjugates |
ATE447611T1 (de) | 2003-08-18 | 2009-11-15 | Univ California | Polypeptid-display-bibliotheken und verfahren zur herstellung und verwendung davon |
KR20080027291A (ko) | 2005-06-01 | 2008-03-26 | 맥시겐 홀딩스 엘티디 | 피이지화된 지-씨에스에프 폴리펩타이드 및 그 제조방법 |
US7550433B2 (en) * | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
EP1919931A4 (en) | 2005-08-31 | 2010-01-20 | Univ California | CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USE THEREOF |
WO2007098548A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
WO2009014726A1 (en) | 2007-07-26 | 2009-01-29 | The Regents Of The University Of California | Methods for enhancing bacterial cell display of proteins and peptides |
US10071109B2 (en) | 2013-11-06 | 2018-09-11 | Molecular Templates, Inc. | Predictive biomarker for hypoxia-activated prodrug therapy |
US20220185857A1 (en) * | 2019-03-28 | 2022-06-16 | Orionis Biosciences, Inc. | Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2069746A1 (en) * | 1990-09-28 | 1992-03-29 | Jonathan I. Rosen | Hybrid growth factors |
US5376367A (en) * | 1991-11-22 | 1994-12-27 | Immunex Corporation | Fusion proteins comprising MGF and IL-3 |
US6057133A (en) * | 1992-11-24 | 2000-05-02 | G. D. Searle | Multivariant human IL-3 fusion proteins and their recombinant production |
US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
US5635599A (en) * | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
-
1997
- 1997-10-23 KR KR10-1999-7003635A patent/KR100497423B1/ko not_active IP Right Cessation
- 1997-10-23 BR BR9713668-9A patent/BR9713668A/pt not_active Application Discontinuation
- 1997-10-23 CZ CZ19991323A patent/CZ295843B6/cs not_active IP Right Cessation
- 1997-10-23 CA CA002268742A patent/CA2268742A1/en not_active Abandoned
- 1997-10-23 AU AU51652/98A patent/AU725547B2/en not_active Ceased
- 1997-10-23 IL IL12956597A patent/IL129565A0/xx unknown
- 1997-10-23 RO RO99-00480A patent/RO120919B1/ro unknown
- 1997-10-23 NZ NZ335382A patent/NZ335382A/xx unknown
- 1997-10-23 RU RU99111071/13A patent/RU2245887C2/ru not_active IP Right Cessation
- 1997-10-23 PL PL97333023A patent/PL333023A1/xx unknown
- 1997-10-23 JP JP51975498A patent/JP2001504689A/ja not_active Abandoned
- 1997-10-23 WO PCT/US1997/020037 patent/WO1998017810A2/en not_active Application Discontinuation
- 1997-10-23 EP EP97946495A patent/EP0935663A2/en not_active Withdrawn
- 1997-10-27 ZA ZA979607A patent/ZA979607B/xx unknown
- 1997-10-27 TW TW086116018A patent/TW591035B/zh not_active IP Right Cessation
- 1997-10-27 TW TW093111460A patent/TW200413407A/zh unknown
- 1997-10-28 AR ARP970104979A patent/AR010041A1/es unknown
-
1999
- 1999-04-23 NO NO991948A patent/NO991948L/no not_active Application Discontinuation
-
2005
- 2005-02-24 RU RU2005105360/13A patent/RU2005105360A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO991948D0 (no) | 1999-04-23 |
TW591035B (en) | 2004-06-11 |
RO120919B1 (ro) | 2006-09-29 |
RU2245887C2 (ru) | 2005-02-10 |
KR100497423B1 (ko) | 2005-07-07 |
BR9713668A (pt) | 2000-03-08 |
CZ295843B6 (cs) | 2005-11-16 |
EP0935663A2 (en) | 1999-08-18 |
NO991948L (no) | 1999-06-23 |
RU2005105360A (ru) | 2006-08-10 |
CA2268742A1 (en) | 1998-04-30 |
AU725547B2 (en) | 2000-10-12 |
IL129565A0 (en) | 2000-02-29 |
KR20000052812A (ko) | 2000-08-25 |
WO1998017810A2 (en) | 1998-04-30 |
JP2001504689A (ja) | 2001-04-10 |
ZA979607B (en) | 1999-04-28 |
WO1998017810A3 (en) | 1998-10-15 |
CZ132399A3 (cs) | 1999-12-15 |
PL333023A1 (en) | 1999-11-08 |
TW200413407A (en) | 2004-08-01 |
NZ335382A (en) | 2001-03-30 |
AU5165298A (en) | 1998-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR010041A1 (es) | Agonistas multifuncionales quimericos de receptores de hematopoyetina | |
IS1916B (is) | Estrógen gerandefni/mótefni, notkun þeirra og milliefni til framleiðslu þeirra | |
ATE218708T1 (de) | Elektrochemischer affinitätsassay | |
DK0529065T3 (da) | Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister | |
DE69711519T2 (de) | Carbazolanaloge als selektive beta3-adrenergische Agonisten | |
NO20006220D0 (no) | <beta>2-adrenergistiske reseptoragonister | |
DK0964874T3 (da) | CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf | |
DK0760857T3 (da) | Receptor for onkostatin M | |
ES2123482T3 (es) | Receptor de estrogeno. | |
ES2192060T3 (es) | Analisis de bioluminiscencia para agonistas o antagonistas de un receptor acoplado al calcio. | |
BR9714355A (pt) | Novos agonistas de receptor flt3 | |
DE69506826T2 (de) | 5-HT4 Rezeptoragonisten | |
SV1998000142A (es) | Agonistas selectivos de beta3 adrenergicos ref. x-10907 | |
DE69723527D1 (de) | Halter für rohrförmige Komponenten | |
DK161860C (da) | Fremgangsmaade til paavisning af det vigtigste ydre membranprotein af chlamydia trachomatis | |
BR9406616A (pt) | Método para triagem de agonistas receptores | |
AU2813297A (en) | Mammalian mixed lymphocyte receptors, chemokine receptors {mmlr-ccr} | |
DK340987D0 (da) | Tricykliske forbindelser, som er agonister af cholinerge receptorer, fremgangsmaade til fremstilling deraf, samt laegemidler indeholdende disse | |
DE69737326D1 (de) | Transkriptions zwischen faktor-2 tif2 | |
BR9808514A (pt) | Proteìnas quiméricas do ligante flt3 | |
DE69941406D1 (de) | IL-6 Rezeptor IL-6-gekoppeltes Fusionsprotein | |
AU3249997A (en) | Method of assaying compounds which affect the activity of g protein-coupled receptors based on measurement of receptor oligomerization | |
DE29609222U1 (de) | Probenehmer für Flüssigkeiten | |
NO984233L (no) | Cytokin kalt lerk-8 | |
DE29780368U1 (de) | Probenehmer für Flüssigkeiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |